Tag: vaccines

Federal Vaccine Advisory Committee Votes to End Universal Hepatitis B Vaccine Recommendation for Babies

A federal advisory committee voted on Friday to end the universal hepatitis B vaccine recommendation for newborn babies – a decision which will now go to the U.S. Centers for Disease Control and Prevention (CDC) director for final approval.

The Advisory Committee on Immunization Practices (ACIP), the CDC’s vaccine advisers, determined in an 8-3 vote to narrow the recommendation. Instead of recommending the shot for all newborn babies, the advisory board is opting to recommend it only for newborns whose mothers test positive for the virus. “Women whose hepatitis B status is negative or unknown should talk with their doctors about vaccination, the recommendation says,” according to NPR.

“If you are a baby that was born to a mother that was tested negative for Hep B, you need to realize, as a parent, that your risk of infection throughout your early stage of life and probably throughout most of your childhood, is extremely low to the extent that it’s even hard to quantify how low. It is, it’s probably one in several millions [sic],” Professor Retsef Levi – a member of the ACIP – said in a clip shared by the CDC.

“And that means that, as a parent, we encourage you, in consultation with your physician, to think very carefully. Do you want to expose your child, your baby, to an intervention that could have some potential harms when the risk is so low?” he asked. “And mind you that we are talking about a very, very young baby in the first few months of their life, where they are not fully developed.”

Keep reading

WHO–Gates Unveils Blueprint For Global Digital ID, AI-Driven Surveillance, & Life-Long Vaccine Tracking For Everyone

In a document published in the October Bulletin of the World Health Organization and funded by the Gates Foundation, the World Health Organization (WHO) is proposing a globally interoperable digital-identity infrastructure that permanently tracks every individual’s vaccination status from birth.

The dystopian proposal raises far more than privacy and autonomy concerns: it establishes the architecture for government overreach, cross-domain profiling, AI-driven behavioral targeting, conditional access to services, and a globally interoperable surveillance grid tracking individuals.

It also creates unprecedented risks in data security, accountability, and mission creep, enabling a digital control system that reaches into every sector of life.

Keep reading

CDC Contractor Exposes What Really Drove the Dramatic Drop in Hepatitis B Cases — Hint: It Wasn’t the Vaccine

A very important meeting is underway as ACIP, the CDC’s Advisory Committee on Immunization Practices, decides whether the Hepatitis B vaccine — recommended for all newborns since 1991 — should continue to be given in the first days of life or whether that decision should ultimately be left to parents.

As of today, Hepatitis B vaccination is required for public school attendance in nearly every state in the United States. If ACIP votes to end the universal birth-dose recommendation and limit it only to infants born to mothers who test positive for hepatitis B, that long-standing school mandate could be displaced to uncertain ground, since most states base their school requirements on ACIP recommendations.

Hepatitis B is a viral infection primarily transmitted through blood and bodily fluids, most commonly through sexual contact, needle sharing, or exposure during birth. Mothers are routinely tested during pregnancy to determine whether they are hepatitis B positive and at risk of transmitting the virus to their baby. And with only about 0.5% of births involving a mother who tests positive, it continues to raise questions about why the vaccine is recommended for every child on the first day of life.

Also, because newborns don’t engage in sexual activity or needle sharing, the universal vaccination recommendation has puzzled many parents for decades, who wonder why a sexually transmitted or bloodborne illness requires immunization at birth.

Many questions about the safety of the hepatitis B vaccine have been raised by figures such as Robert Kennedy Jr., Dr. Sherri Tenpenny, Dr. Casey Means, and countless concerned parents.

But one CDC contractor, Dr. Cynthia Nevison, walked into the ACIP meeting and raised another critical question: has universal Hepatitis B vaccination, after 34 long years, even lowered Hepatitis B cases on a population level? Dr. Nevison’s answer to that question might surprise you.

And if not the vaccine, why did Hepatitis B cases plummet after 1991? Dr. Nevison addressed that question, too.

Keep reading

Colorado Medical School Will Pay $10.3 Million After Denying Religious Exemptions for COVID Vaccine

The University of Colorado Anschutz School of Medicine will pay more than $10.3 million to 18 faculty and students whose religious exemptions to the school’s mandatory COVID-19 vaccine policy were denied, a group representing the plaintiffs announced Monday.

The lawsuit challenged the university’s refusal to accommodate sincerely held religious objections to the COVID-19 vaccine. The plaintiffs, who sued anonymously, included physicians, medical students, nurses and administrative staff.

The Thomas More Society, which filed the lawsuit and represents clients in religious liberty cases nationwide, stated that the settlement is a rare instance in which plaintiffs recovered monetary damages under the First Amendment for a government COVID-19 vaccine mandate.

Michael McHale, senior counsel at the Thomas More Society, said the resolution cannot undo the harm inflicted on the plaintiffs.

“No amount of compensation or course-correction” can make up for the damage caused by the university’s vaccine mandate, McHale said. “At great, and sometimes career-ending, costs, our heroic clients fought for the First Amendment freedoms of all Americans who were put to the unconscionable choice of their livelihoods or their faith.”

Details of the settlement, which followed more than a year of negotiations, were not released. According to the Thomas More Society, the school agreed to cover damages, tuition and attorneys’ fees.

The settlement ends nearly five years of related litigation in state and federal courts.

Keep reading

Hep B Shot: Not Proven Safe or Effective for Kids

I. Junk Science Clinical Trials as the Basis for FDA Licensure of Hepatitis B Vaccines in the U.S. 

The Advisory Committee on Immunization Practices (ACIP) will discuss hepatitis B vaccines at their meeting on December 4 and 5. In this article I will lay out the case for removing hepatitis B vaccines from the CDC childhood schedule altogether.

As the Informed Consent Action Network has demonstrated, the hepatitis B vaccines Recombivax and Engerix — injected into the vast majority of American children at birth, one month, and six months of age — never should have been licensed by the FDA in the first place. 

The clinical trials for Recombivax and Engerix:

  • did not include a proper saline placebo control group; 
  • were too small to detect uncommon adverse events; and
  • were too short to detect the majority of harms (the Recombivax trials monitored safety for just five days, the Engerix trials monitored solicited adverse events for just four days).

II. Hepatitis B Vaccines Are Associated with Autism 

The real world data that are available on the safety of hepatitis B vaccines are horrifying. When autism rates in the US exploded in the 1990s, the CDC looked into the possible role of vaccines. They assigned one of their senior scientists, Thomas Verstraeten, at the Epidemic Intelligence Service, to do the analysis. At the time, hepatitis B vaccines had mercury (thimerosal) in them. Dr. Verstraeten found that children in the highest exposure group had an 11.35x increased relative risk of autism.

Keep reading

Is President Trump really so concerned about the flow of drugs ‘poisoning Americans,’ when he just pardoned a notorious drug trafficker and warp speeds harmful pharmaceuticals?

Anyone who still believes the Trump administration’s newly scheduled wars in Latin America are in any way related to stopping drugs from killing Americans is not paying attention to the full spectrum of policies coming out of this administration.

Instead of listening to Trump’s many bombastic public statements in a vacuum, let’s examine the record of his actions.

This administration has an obsession with drugs. Even known harmful drugs have been embraced and promoted by President Trump in his first and second terms.

There is now plenty of evidence that Trump’s Operation Warp Speed project, which he placed under the direction of former pharma executive General Gustav Perna and the U.S. military, led to mega-deaths in the United States and the world. Speed came at the cost of any valid clinical trials, with needles entering arms under Emergency Use Authorization with only two months of safety data on the FDA’s books. When it comes to experimental new medicines or treatments, you don’t gamble with people’s lives. There are reasons why it takes 10-15 years to get a vaccine through the approval process, but Trump was willing to make that gamble. And it paid off in the form of record profits for Pfizer and Moderna.

The latest evidence of that was just last week when Trump’s own FDA finally fessed up and told us the Covid shots led to the deaths of at least 10 children during trials (this is based on VAERS data which has been proven to be underreported by a factor of at least 10). This was kept hidden from the American public, along with all the other reams of evidence showing that the shots killed people of all ages and continues to do so.

As a result, hundreds of thousands of Americans report suffering vaccine injuries, as even The New York Times is reporting.

Keep reading

Teen Who Died 5 Days After Pfizer Vaccine Among 10 Deaths FDA Cited In Leaked Memo

Last week, a leaked FDA memo acknowledged that at least ten children died “after and because of” the COVID-19 vaccine in the U.S.

None of those children had been identified — until now.

One of them is now understood to be Ernesto Ramirez Jr., a 16-year-old from Texas who collapsed and died five days after receiving the Pfizer COVID-19 shot.

“Junior,” as he is known, is among the cases at the center of the U.S. Food and Drug Administration’s (FDA) internal investigation into pediatric deaths following COVID-19 vaccination.

For his father, Ernest Ramirez, the past four years have been consumed by grief, tireless campaigning and what he describes as a “living hell.”

Now, for the first time, he believes the FDA has acknowledged what he has always known — the vaccine took his child.

“That’s the poison that killed my son,” he told me.

A father fights for his son

Junior was healthy, athletic and inseparable from his dad. Ernest raised him alone.

“We were always together, we were never apart,” he said. “Like I’ve always said, he was my best friend … We were buddies.”

Five days after the Pfizer shot, Junior went to the park with a neighbor to play basketball.

“They started running and he just collapsed,” Ernest said.

Paramedics rushed him to the hospital, but attempts to revive him failed. Ernest still remembers the bluntness of the staff.

“Yeah, you can go home now, your son’s dead,” is how he recalls the doctor’s tone.

He could not return to the empty house.

At first, he had no idea the vaccine could have been involved. It wasn’t until cardiologist Dr. Peter McCullough reviewed the records that Ernest heard the words that changed everything.

Keep reading

Vaccine Stocks Drop After FDA Memo Links COVID Shots To Child Deaths

Vaccine stocks slumped Monday after an explosive memo from FDA vaccine chief Vinay Prasad surfaced late Friday, signaling the agency is preparing to roll out tough restrictions on new vaccines for children. Prasad described a “profound revelation” linking Covid shots to at least ten deaths in children. 

By late morning, Vaccine makers dropped on the memo: Moderna -6%, BioNTech -4.3%, Novavax -4%, Vaxcyte -6.6%.

Wall Street analysts weighed in on the memo, and all agreed it introduces a new regulatory overhang for vaccine stocks.

Here’s what the research desks told clients:

William Blair, Myles R. Minter (rates the MRNA market perform)

  • “Our interpretation of the memo is that CBER will focus its efforts on the younger 12- to 24-year-old male population for newly approved Covid-19 vaccines where the myocarditis risk is highest”
  • If new regulatory restrictions were to be implemented in the higher myocarditis risk population, analysts see further headwinds toward Moderna’s declining Covid-19 franchise “alongside further negative sentiment that this memo and subsequent actions may generate”
  • Analyst says Pfizer, BioNTech, Novavax and Sanofi could also be impacted
  • “The memo also indicates several upcoming reforms to the CBER vaccine regulatory pathway, most notably the “demand” for pre- market randomized trials assessing clinical endpoints, not just immunogenicity, for most new vaccine products”

Keep reading

Pfizer buries data showing mRNA flu vaccine bombed in trial with elderly, not much better under 65

wo years ago, Pfizer anticipated that sales of its rebound-prone COVID-19 oral antiviral Paxlovid and fully approved mRNA COVID vaccine Comirnaty would plummet, but good news appeared on the horizon: The drugmaker’s mRNA flu vaccine did well in phase 3 trials in ages 18-64, and Pfizer expected to release results from the 65-and-up cohort “later this year.”

The results are finally in: Compared to a standard flu shot, the mRNA vaccine was associated with six times as many adverse events as infections prevented in adults under 65, and it outright failed in elderly people, associated with more deaths and both minor and serious injuries, from injection-site swelling to kidney problems.

The company buried the long-delayed elderly results on the government’s clinical trials website this spring, more than a year late and without announcing them to the public or investors, and gave an optimistic take on the under-65 results in the New England Journal of Medicine last week, while admitting the mRNA shot was “associated with more reactogenicity events.”

Australian and American drug industry journalists dug into the two arms of the trial, predicting mRNA jabs for flu would face an uphill climb with Trump administration regulators, who have already canceled nearly $500 million in federal projects and contracts that went toward mRNA vaccine development.

Pfizer used the same testing structure for mRNA flu shots as for its COVID shots and still found only an absolute difference of 0.32% for under-65s, requiring vaccination by 300 people to “prevent a single mild, self-limiting illness,” physician-turned-investigative journalist Maryanne Demasi wrote in an X thread summarizing her deep-dive review.

“Put simply, it’s a manufacturer-funded trial, written largely by Pfizer employees & finds its best efficacy in the endpoint that requires all samples to be shipped to a Pfizer-run central lab for adjudication,” Demasi said.

Keep reading

EXPOSED: US Labs Breeding Deadly Foreign Ticks in Bid for mRNA Vaccines

U.S. government-funded labs are actively breeding colonies of exotic Hyalomma ticks imported from Africa to study Crimean-Congo Hemorrhagic Fever (CCHF), a brutal tick-borne virus with a 30% mortality rate that’s never been detected in America.

This high-stakes research, aimed at developing mRNA vaccines and analyzing transmission in livestock, is raising red flags among experts who warn of catastrophic lab leaks that could unleash the disease on U.S. soil, devastating agriculture and public health.

The program involves multiple facilities, including the USDA’s Agricultural Research Service in Manhattan, Kansas (tied to the National Bio and Agro-Defense Facility, formerly on Plum Island), UC Davis in California, and Texas Tech in Lubbock, Texas, according to research from the White Coat Waste project, first reported by The Highwire.

These sites are establishing tick colonies to experiment on CCHF transmission in cattle, sheep, and goats, assessing risks for the virus establishing itself here based on climate and ecology.

“The White Coat Waste Project uncovered 10 existing USDA contracts to work on mRNA vaccines, including one that is studying Crimean-Congo Hemorrhagic Fever (CCHF), a highly pathogenic tick-borne disease with a 10-40% case fatality rate,” The Highwire reports. “The research grant is given to the Agricultural Research Service in Manhattan, Kansas, in combination with researchers at the National Bio and Agro-Defense Facility (NBAF), which was formerly on Plum Island, where researchers were studying Lyme disease near Lyme, Connecticut, where the first outbreak occurred.”

CCHF, first identified in Crimea in 1944, causes severe symptoms and can spread from ticks to animals or humans, and even person-to-person.

There’s no widely licensed vaccine, only a dubious Soviet-era one from 1970.

Funding flows from USDA contracts for mRNA vaccine development, including 10 ongoing deals specifically targeting CCHF.

EcoHealth Alliance, infamous for its role in COVID origins research, snagged a $3.7 million Department of Defense grant from 2020-2024 to study CCHF as part of “combating weapons of mass destruction.”

The Highwire notes, “WCWP was the organization that first uncovered that EcoHealth Alliance was involved in gain-of-function research with coronaviruses at the Wuhan Institute of Virology, approved by NIAID head Dr. Anthony Fauci, which the FBI and CIA both state is the most likely source of the COVID-19 virus that sparked a worldwide pandemic. WCWP celebrated the announcement that the CDC will be closing all monkey studies by the end of the year.”

Another USDA contract, running through March 2026, supports the core research.

Critics are blasting this as reckless madness.

Keep reading